PREMARKET ALERT: OSI Pharmaceuticals (OSIP)

Posted in General 
July 13th, 2009

OSI Pharmaceuticals Inc. (Nasdaq: OSIP) shares are up 9 percent to $31 on premarket volume of about 13,500 shares as of 8:15 Eastern. The company announced new data from its Phase III Saturn study of Tarceva. The drug improved overall survival when used immediately after initial chemotherapy in lung cancer patients. — Mike Tarsala

Comments are closed

-->